Shared Decision-Making for IgAN Treatment

Key Takeaways

• Biomarkers, including genetic mutations and protein expressions, are vital for predicting disease progression and treatment response.
• Advanced diagnostic techniques are essential for identifying molecular and cellular indicators that inform patient prognosis.
• Clinical indicators like tumor size, stage, and overall health status are crucial in assessing disease outcomes.
• Personalized medicine utilizes biomarkers to customize treatment plans, improving therapeutic efficacy and patient survival.